These outcomes depicted that SST has the aptitude to inhibit the stimulation of microglia and the NF-κB mechanism, and, consequently, declines the nerve cell inflammation and oxidative destruction, and finally suppresses the DArgic nerve cell deprivation elicited by LPS exposure in nerve cell deteriorating diseases such as PD [29]. The gene discussed is NFKB1; the disease is Parkinson disease.